AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23665051 — intervention group
Group type: COMPARATOR
Intervention: Upright Posture
Number of subjects: 22
Study 21504953 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal stimulation therapy (standard rehabilitation plus approximately 30-40 minutes of thermal stimulation daily for six weeks)
Number of subjects: 36
Study 21504953 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard rehabilitation only)
Number of subjects: 36
Study 19644227 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine (2-8 mg/d)
Number of subjects: 27
Study 19644227 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate (10-20 mg/d)
Number of subjects: 27
Study 17853751 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion combined with nerve growth factor and rehabilitation training
Number of subjects: 100
Study 17853751 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training only (Control)
Number of subjects: 100
Study 15201718 — intervention group
Group type: EXPERIMENTAL
Intervention: Spun-cast pHEMA lens
Number of subjects: 34
Study 15201718 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast-molded pHEMA lens
Number of subjects: 34
Study 15201718 — intervention group
Group type: EXPERIMENTAL
Intervention: HEMA/GMA lens
Number of subjects: 34
Study 15201718 — intervention group
Group type: EXPERIMENTAL
Intervention: Other pHEMA lenses (lathing and cast molding)
Number of subjects: 34
Study 11685302 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 26
Study 11685302 — intervention group
Group type: COMPARATOR
Intervention: Endovascular treatment
Number of subjects: 26
Study 9135360 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam 0.025 mg kg‐1 i.m.
Number of subjects: 6
Study 9135360 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam 0.075 mg kg‐1 i.m.
Number of subjects: 6
Study 9135360 — intervention group
Group type: COMPARATOR
Intervention: control (no midazolam administration)
Number of subjects: 6
Study 8361252 — intervention group
Group type: EXPERIMENTAL
Intervention: VA‐ADHC services
Number of subjects: 0
Study 8361252 — intervention group
Group type: COMPARATOR
Intervention: Customary care
Number of subjects: 0
Study 8361252 — intervention group
Group type: EXPERIMENTAL
Intervention: Contract ADHC
Number of subjects: 0
Study 8361252 — intervention group
Group type: EXPERIMENTAL
Intervention: VA‐ADHC
Number of subjects: 0
Study 3706112 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 27
Study 3706112 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 30458778 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs)
Number of subjects: 6111
Study 30458778 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Assistants (MAs)
Number of subjects: 6111
Study 30458778 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6111
Study 27600828 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated by a fourth-year student who is a Gold Humanism Honor Society member (GHHS)
Number of subjects: 186
Study 27600828 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated by a volunteer non-GHHS student
Number of subjects: 186
Study 27600828 — intervention group
Group type: COMPARATOR
Intervention: Non-facilitated groups
Number of subjects: 186
Study 27600828 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 186
Study 24239324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg/kg primaquine
Number of subjects: 468
Study 24239324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg primaquine
Number of subjects: 468
Study 24239324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg primaquine
Number of subjects: 468
Study 24239324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study 23107470 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Western medicine and Bu‐Fei Jian‐Pi granules, Bu‐Fei Yi‐Shen granules, and Yi‐Qi Zi‐Shen granules
Number of subjects: 352
Study 20660231 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic external fixation
Number of subjects: 70
Study 18400400 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (optimal fixed dosages of 300, 450, 600 mg/d)
Number of subjects: 1051
Study 18400400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1051
Study 16085585 — intervention group
Group type: EXPERIMENTAL
Intervention: MDCT angiography
Number of subjects: 25
Study 16085585 — intervention group
Group type: COMPARATOR
Intervention: MPI
Number of subjects: 25
Study 12583552 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day treatment course with oral moxifloxacin (MXF)
Number of subjects: 476
Study 12583552 — intervention group
Group type: COMPARATOR
Intervention: 7-day course with i.m. ceftriaxone (CRO)
Number of subjects: 476
Study 12197575 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg
Number of subjects: 518
Study 12197575 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 24 microg
Number of subjects: 518
Study 12197575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study 9640223 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO) at a dose of 150 U/kg/dose subcutaneously three times/week for a minimum of 12 weeks
Number of subjects: 20
Study 9640223 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rhEPO)
Number of subjects: 20
Study 9640223 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 8126238 — intervention group
Group type: EXPERIMENTAL
Intervention: Plax
Number of subjects: 20
Study 8126238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 2530318 — intervention group
Group type: EXPERIMENTAL
Intervention: Circadian patterned variable rate infusion of floxuridine (FUDR)
Number of subjects: 54
Study 2530318 — intervention group
Group type: COMPARATOR
Intervention: Constant rate infusion of floxuridine (FUDR)
Number of subjects: 54
Study 2530318 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-modified FUDR infusion
Number of subjects: 54
Study 2530318 — intervention group
Group type: EXPERIMENTAL
Intervention: FUDR infusion
Number of subjects: 54
Study 1067726 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol chewing gum (n = 36)
Number of subjects: 96
Study 1067726 — intervention group
Group type: COMPARATOR
Intervention: Sucrose chewing gum (n = 32)
Number of subjects: 96
Study 1067726 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chewing gum, n = 28)
Number of subjects: 96
Study 31242884 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 0
Study 28343659 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg zinc oxide (n=144)
Number of subjects: 602
Study 28343659 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg ferrous fumarate (n=148)
Number of subjects: 602
Study 28343659 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron and zinc together (n=148)
Number of subjects: 602
Study 28343659 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=151)
Number of subjects: 602
Study 26148003 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Fitness Counts (mFC)
Number of subjects: 51
Study 26148003 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Resistance Exercise Training (PRET)
Number of subjects: 51
Study 23672385 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 21
Study 23672385 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining
Number of subjects: 21
Study 21689865 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized buccal midazolam
Number of subjects: 169
Study 21689865 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized intranasal midazolam
Number of subjects: 169
Study 21689865 — intervention group
Group type: COMPARATOR
Intervention: Oral midazolam
Number of subjects: 169
Study 20120262 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulated motion of structurally similar objects
Number of subjects: 0
Study 20120262 — intervention group
Group type: COMPARATOR
Intervention: Static controls
Number of subjects: 0
Study 20120262 — intervention group
Group type: COMPARATOR
Intervention: Scrambled controls
Number of subjects: 0
Study 16483431 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration of metronidazole (group B)
Number of subjects: 60
Study 16483431 — intervention group
Group type: COMPARATOR
Intervention: Irrigation with saline (group A)
Number of subjects: 60
Study 12603860 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical glucocorticoid (clobetasol), applied for 3 days
Number of subjects: 0
Study 12603860 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical applications of an equimolar distribution of free fatty acids, cholesterol, and ceramides
Number of subjects: 0
Study 10934653 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 160
Study 10934653 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 160
Study 9007943 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based care
Number of subjects: 0
Study 9007943 — intervention group
Group type: EXPERIMENTAL
Intervention: Research studies evaluated using rules of evidence
Number of subjects: 0
Study 8165610 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (adapted doses, continuous intravenous)
Number of subjects: 91
Study 8165610 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin (1 mg/kg every twelve hours, subcutaneously)
Number of subjects: 91
Study 30807970 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 0
Study 30807970 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATX)
Number of subjects: 0
Study 30807970 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 0
Study 30807970 — intervention group
Group type: EXPERIMENTAL
Intervention: miRNA-107
Number of subjects: 0
Study 26263787 — intervention group
Group type: EXPERIMENTAL
Intervention: O. hupensis snail crushers
Number of subjects: 109
Study 26263787 — intervention group
Group type: COMPARATOR
Intervention: Crushing method
Number of subjects: 109
Study 26263787 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushing and shedding method with O. hupensis snail crushers
Number of subjects: 109
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Achromatic (black/white) patterns at 3 and 12 cpd
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Tritan (black/purple, black/yellow) patterns
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Protan/deutan (black/red, black/green) patterns
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 cpd gratings
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 cpd gratings
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast sensitivity measures
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual migraine/headache triggers
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual discomfort scale
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Achromatic visual discomfort measures
Number of subjects: 42
Study 23464876 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromatic discomfort measures
Number of subjects: 42
Study 20804506 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidants (AOx) alone
Number of subjects: 0
Study 20804506 — intervention group
Group type: COMPARATOR
Intervention: Sunscreen (SS) alone (SPF 25)
Number of subjects: 0
Study 20804506 — intervention group
Group type: EXPERIMENTAL
Intervention: AOx plus SS
Number of subjects: 0
Study 20804506 — intervention group
Group type: COMPARATOR
Intervention: Sunscreen (SS) plus AOx only
Number of subjects: 0
Study 20804506 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 20804506 — intervention group
Group type: COMPARATOR
Intervention: ssUVR only
Number of subjects: 0
Study 20804506 — intervention group
Group type: COMPARATOR
Intervention: Untreated (neither ssUVR nor product)
Number of subjects: 0
Study 19255393 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickle cell disease with osteomyelitis (case patients)
Number of subjects: 124
Study 19255393 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of fever
Number of subjects: 124
Study 19255393 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of pain
Number of subjects: 124
Study 19255393 — intervention group
Group type: EXPERIMENTAL
Intervention: Swelling of the affected limb
Number of subjects: 124
Study 19255393 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 1 painful site
Number of subjects: 124
Study 17061441 — intervention group
Group type: EXPERIMENTAL
Intervention: High vegetables intake (last quintile)
Number of subjects: 6427
Study 17061441 — intervention group
Group type: EXPERIMENTAL
Intervention: High fruits intake
Number of subjects: 6427
Study 17061441 — intervention group
Group type: COMPARATOR
Intervention: Control group (lower vegetables intake, first quintile)
Number of subjects: 6427
Study 15019661 — intervention group
Group type: EXPERIMENTAL
Intervention: ELP bioprosthesis
Number of subjects: 81
Study 15019661 — intervention group
Group type: COMPARATOR
Intervention: MM bioprosthesis
Number of subjects: 81
Study 15019661 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both valves
Number of subjects: 81
Study 11697840 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly docetaxel 36 mg/m2 i.v. administered weekly for six consecutive weeks followed by two weeks without treatment
Number of subjects: 25
Study 9783561 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic patients
Number of subjects: 44
Study 9783561 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 44
Study 9783561 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption during follow-up
Number of subjects: 44
Study 8151485 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine-prilocaine 5% cream (EMLA)
Number of subjects: 96
Study 8151485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 3143625 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition and nil by mouth (n = 17)
Number of subjects: 51
Study 3143625 — intervention group
Group type: EXPERIMENTAL
Intervention: Defined formula diet administered through a nasogastric tube (n = 19)
Number of subjects: 51
Study 3143625 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial parenteral nutrition and oral food (n = 15)
Number of subjects: 51
Study 30457967 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 0
Study 30457967 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy
Number of subjects: 0
Study 30457967 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 0
Study 30457967 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 0
Study 28892156 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) in beverage at 0, 8, 12, and 16 g
Number of subjects: 53
Study 28892156 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydextrose (PDX) in bar at 0 and 12 g
Number of subjects: 53
Study 25748110 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care improvement intervention at health centres
Number of subjects: 0
Study 23017510 — intervention group
Group type: EXPERIMENTAL
Intervention: Saw palmetto treatment
Number of subjects: 357
Study 20642342 — intervention group
Group type: EXPERIMENTAL
Intervention: Center based rehabilitation
Number of subjects: 436
Study 20642342 — intervention group
Group type: EXPERIMENTAL
Intervention: Home based rehabilitation
Number of subjects: 436
Study 20642342 — intervention group
Group type: EXPERIMENTAL
Intervention: Mix of center based and home based rehabilitation
Number of subjects: 436
Study 20642342 — intervention group
Group type: EXPERIMENTAL
Intervention: Center based rehabilitation with home based non interventional supplementary visits
Number of subjects: 436
Study 18803093 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer Technique (TT)
Number of subjects: 181
Study 18803093 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer Technique and Physical Training (TTPT)
Number of subjects: 181
Study 18803093 — intervention group
Group type: COMPARATOR
Intervention: Control (usual routine)
Number of subjects: 181
Study 16586079 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-tetrofosmin SPECT
Number of subjects: 28
Study 16586079 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-fluorodeoxyglucose (FDG) PET
Number of subjects: 28
Study 16586079 — intervention group
Group type: EXPERIMENTAL
Intervention: Preserved flow with decreased glucose metabolism
Number of subjects: 28
Study 16586079 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased flow with preserved glucose metabolism
Number of subjects: 28
Study 12740741 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH alone (100 microg)
Number of subjects: 8
Study 12740741 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone (EX)
Number of subjects: 8
Study 12740741 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH + EX (100 microg GHRH with exercise)
Number of subjects: 8
Study 10970684 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with SRL172 (Mycobacterium vaccae)
Number of subjects: 28
Study 10970684 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 28
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive use
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and cholesterol levels
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and menopausal status
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: FVIIa levels
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, sex, and menopause-related changes in FVIIc
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: FVIIa
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: FVIIc and FVIIa levels
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean values of FVIIc and FVIIa
Number of subjects: 684
Study 8792771 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal women
Number of subjects: 684
Study 1467127 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low protein diet (0.4 g of protein/kg b.w./day) supplemented with essential amino acids
Number of subjects: 21
Study 1467127 — intervention group
Group type: COMPARATOR
Intervention: Conventional low protein diet (0.6 g of protein/kg b.w./day)
Number of subjects: 21
Study 6419809 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine
Number of subjects: 238
Study 6419809 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 238
Study 6419809 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 238
Study 6419809 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 238
Study 6419809 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 238
Study 6419809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 30556832 — intervention group
Group type: COMPARATOR
Intervention: NRT (Nicotine Replacement Therapy)
Number of subjects: 624
Study 30556832 — intervention group
Group type: COMPARATOR
Intervention: NRT plus text messaging
Number of subjects: 624
Study 30556832 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT plus text messaging plus proactive counseling via mobile phone
Number of subjects: 624
Study 28097646 — intervention group
Group type: EXPERIMENTAL
Intervention: Visuospatial intervention programme (10-week, 20 hours of activities)
Number of subjects: 186
Study 28097646 — intervention group
Group type: COMPARATOR
Intervention: Standard mathematics instruction (control group)
Number of subjects: 186
Study 27416906 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-Camp Intervention Arm (DCIA)
Number of subjects: 115
Study 27416906 — intervention group
Group type: COMPARATOR
Intervention: Standard Intervention Arm (SIA)
Number of subjects: 115
Study 24273179 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervarix
Number of subjects: 92
Study 24273179 — intervention group
Group type: COMPARATOR
Intervention: Gardasil
Number of subjects: 92
Study 22896733 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice White Grease (CWG) diet
Number of subjects: 391
Study 22896733 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-Vegetable blend (A-V) diet
Number of subjects: 391
Study 22896733 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 391
Study 19254671 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (45 mg, 3 times/day, for 24 hours)
Number of subjects: 23
Study 19254671 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine
Number of subjects: 23
Study 19254671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 17202549 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 112
Study 17202549 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 112
Study 17202549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 15037335 — intervention group
Group type: EXPERIMENTAL
Intervention: PANSS cognitive factor
Number of subjects: 167
Study 15037335 — intervention group
Group type: EXPERIMENTAL
Intervention: Five PANSS items (P6, N5, N6, G2, G10)
Number of subjects: 167
Study 11750185 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of d-amphetamine
Number of subjects: 10
Study 11750185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10